Minireviews
Copyright ©The Author(s) 2022.
World J Hepatol. May 27, 2022; 14(5): 923-943
Published online May 27, 2022. doi: 10.4254/wjh.v14.i5.923
Table 1 Histological classification of benign liver lesions
Epithelial tumors (hepatocellular and biliary)
Mesenchymal tumors
Pseudotumor
Hepatocellular adenomaHemangiomaFocal fatty infiltration
Focal nodular hyperplasia LymphangiomaInfection (liver abscess, Echinococcus granulosus)
Biliary cystadenomaSolitary fibrous tumorInflammatory disorder of the liver (pseudotumor, sarcoidosis)
Biliary hamartoma (von Meyenburg Complex)Mesenchymal hamartoma
Table 2 Magnetic resonance contrast agent
Category
Molecule
Structure
Ioniity
Relaxivity
Recommended dose (mmol/kg)
Excretion
ECAsGadoterate meglumine (Dotarem)MacrocyclicIonicStandard0.1Renal
ECAsGadobutrol (Gadavist)MacrocyclicNon-ionicStandard0.1Renal
ECAsGadoteridol (Prohance)MacrocyclicNon-ionicStandard0.1Renal
ECAsGadopentetate dimeglumine (Magnevist)LinearIonicStandard0.1Renal
ECAsGadoversetamide (OptiMark)LinearNon-ionicStandard0.1Renal
ECAsGadodiamide (Omniscan)LinearNon-ionicStandard0.1Renal
HBAGd-EOB-DTPA (Eovist/Primovist)LinearIonicHigh0.02550% renal, 50% biliary
HBAGd-BOPTA (MultiHance)LinearIonicHigh0.15% biliary, 95% renal
BPAGadofosveset trisodium (Ablavar)LinearIonicHigh0.03Renal